The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
All articles
Filters
Search by author
Type a minimum of 3 characters
Type a minimum of 3 characters
Filter by type
All articles
Just accepted article
Ahead of print
Regular article
No elements found. Consider changing the search query.
List is empty.
Showing 1-20 of 4817 articles
An ESC/EAPCI consensus statement on renal denervation; a debate on the future of transcatheter mitral valve replacement; a mini focus on interventional pharmacology, from P2Y12 inhibitors to evolocumab; impact of non-fatal periprocedural major adverse events on ten-year mortality; pathologic responses to abluminal biodegradable versus circumferential durable polymer-coated DES; and more
Capodanno D
March 20, 2023
Clopidogrel: still king of the ring for elective percutaneous coronary intervention!
Montalescot G,
Ferrante A
March 20, 2023 | 10.4244/EIJ-E-23-00003
Effects of PCSK9 inhibitors on platelet function
Räber L,
Ueki Y
March 20, 2023 | 10.4244/EIJ-E-23-00005
Revascularisation, periprocedural events and survival – and the survival of the randomised controlled trial
Lansky A,
Ahmad Y
March 20, 2023 | 10.4244/EIJ-E-23-00004
Periprocedural adverse events after revascularisation: the importance of getting off to a good start
Gaudino M,
Dimagli A
March 20, 2023 | 10.4244/EIJ-E-22-00054
Transcatheter mitral valve replacement will remain a niche therapy: pros and cons
Cohen D,
Ludwig S,
Piazza N
March 20, 2023 | 10.4244/EIJ-E-22-00044
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Barbato E,
Azizi M,
Schmieder RE,
Lauder L,
Böhm M,
Brouwers S,
Bruno RM,
Dudek D,
Kahan T,
Kandzari D,
Lüscher T,
Parati G,
Pathak A,
Ribichini F,
Schlaich M,
Sharp A,
Sudano I,
Volpe M,
Tsioufis C,
Wijns W,
Mahfoud F
March 20, 2023 | 10.4244/EIJ-D-22-00723
Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
Koshy A,
Giustino G,
Sartori S,
Hooda A,
Feng Y,
Snyder C,
Dasgupta S,
Kumar K,
Krishnamoorthy-Melarcode P,
Sweeny J,
Khera S,
Serrao G,
Sharma R,
Dangas G,
Kini A,
Mehran R,
Sharma S
March 20, 2023 | 10.4244/EIJ-D-22-00654
Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-controlled study
Franchi F,
Ortega-Paz L,
Rollini F,
Been L,
Rivas A,
Maaliki N,
Zhou X,
Pineda A,
Suryadevara S,
Soffer D,
Zenni M,
Angiolillo D
March 20, 2023 | 10.4244/EIJ-D-22-00719
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry
Gargiulo G,
Marenna A,
Sperandeo L,
Manzi L,
Avvedimento M,
Simonetti F,
Canonico M,
Paolillo R,
Spinelli A,
Borgia F,
Diserafino L,
Franzone A,
Stabile E,
Piccolo R,
Cirillo P,
Valgimigli M,
Esposito G
March 20, 2023 | 10.4244/EIJ-D-22-00594
Cangrelor for comatose survivors of out-of-hospital cardiac arrest undergoing percutaneous coronary intervention: the CANGRELOR-OHCA study
Kordis P,
Bozic Mijovski M,
Berden J,
Steblovnik K,
Blinc A,
Noc M
March 20, 2023 | 10.4244/EIJ-D-22-00675
Impact of periprocedural major adverse events on 10-year mortality after revascularisation
Kotoku N,
Serruys P,
Ninomiya K,
Soo A,
Masuda S,
Kageyama S,
Revaiah P,
Mack M,
Holmes DR,
Morice M,
Davierwala P,
Mohr F,
Milojevic M,
Kappetein A,
Garg S,
Onuma Y
March 20, 2023 | 10.4244/EIJ-D-22-00681
Early vascular responses to abluminal biodegradable polymer-coated versus circumferential durable polymer-coated newer-generation drug-eluting stents in humans: a pathological study
Kawagoe Y,
Otsuka F,
Onozuka D,
Ishibashi-Ueda H,
Ikeda Y,
Ohta-Ogo K,
Matsumoto M,
Amemiya K,
Asaumi Y,
Kataoka Y,
Nishimura K,
Miyamoto Y,
Noguchi T,
Finn A,
Virmani R,
Hatakeyama K,
Yasuda S
March 20, 2023 | 10.4244/EIJ-D-22-00650
Letter: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
Minten L,
Bennett J,
Dubois C
March 20, 2023 | 10.4244/EIJ-D-22-00998
Reply: Coronary physiology in severe aortic stenosis: solely a matter of increased coronary resting flow?
Sabbah M,
Lønborg J,
Olsen NT,
Engstrøm T
March 20, 2023 | 10.4244/EIJ-D-22-01031
Impact of early changes in cardiac damage following transcatheter aortic valve implantation
Zhou Y,
Zhu Q,
Lin X,
Li H,
Pu Z,
Liu X,
Wang J
March 17, 2023 | 10.4244/EIJ-D-22-00817
Posterior pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: a systematic review and meta-analysis of 25 randomised controlled trials
Abdelaziz A,
Hafez AH,
Elaraby A,
Roshdy MR,
Abdelaziz M,
Eltobgy MA,
Elsayed H,
El-Samahy M,
Elbehbeh NA,
Philip KG,
Abdelaty AM,
Rizk MA,
Al-Tawil M,
AboElfarh HE,
Ramadan A,
Ghaith HS,
Wahsh EA,
Abdelazeem B,
Fayed B
March 16, 2023 | 10.4244/EIJ-D-22-00948
One-year outcomes of transcatheter tricuspid valve repair with the Mistral device
Piayda K,
Bertog S,
Steffan J,
Ilioska-Damköhler P,
Beeri R,
Sievert K,
Sievert H,
Yaron I,
Danenberg HD
March 13, 2023 | 10.4244/EIJ-D-22-01032
Thirty-day and one-year outcomes of the Navitor transcatheter heart valve in patients with aortic stenosis: the prospective, multicentre, global PORTICO NG Study
Sondergaard L,
Walton AS,
Worthley SG,
Smith D,
Chehab B,
Manoharan G,
Yong G,
Bedogni F,
Bates N,
Reardon MJ
March 9, 2023 | 10.4244/EIJ-D-22-01108
One-year outcomes after transcatheter aortic valve implantation with the latest-generation SAPIEN balloon-expandable valve: the S3U registry
Cannata S,
Gandolfo C,
Ribichini F,
van Mieghem N,
Buccheri S,
Barbanti M,
Berti S,
Teles RC,
Bartorelli AL,
Musumeci G,
Piva T,
Nombela-Franco L,
La Spina K,
Palmerini T,
Adrichem R,
Esposito A,
Lopes P,
Olivares P,
Annibali G,
Nicolini E,
Marroquin L,
Tamburino C,
Tarantini G,
Saia F
March 7, 2023 | 10.4244/EIJ-D-22-01022
1
2
3
…
241
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke